Open access
Open access
Powered by Google Translator Translator

Evidence Synopsis: Aspirin Plus Clopidogrel vs Aspirin Alone for Patients at High Risk for Cardiovascular Events

3 Aug, 2018 | 11:36h | UTC

Aspirin Plus Clopidogrel vs Aspirin Alone for Preventing Cardiovascular Events Among Patients at High Risk for Cardiovascular Events – JAMA (free for a limited period)

“Clopidogrel+ASA: Reduced risk for MI and ischemic stroke – Increased risk for major bleeding compared with aspirin alone. Combined therapy is NOT associated with lower mortality.” (via @ehlJAMA see Tweet)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.